Guillem Buxarrais
FounderCEO at Neurofenix London
New York City Metropolitan Area
FoundedNeurofenix London
About
Guillem Singla Buxarrais is a healthcare strategy and innovation professional with 12 years of experience across healthcare delivery, technology, and business strategy, currently serving as a Healthcare Innovation Consultant at Bioness Medical, Inc. As Co-Founder and CEO of Neurofenix, he developed an AI-based virtual neuro-rehabilitation company that supported more than 3,000 patients, partnered with over 40 health systems and academic medical centers, secured Medicare reimbursement, raised $12M in funding, and contributed to five peer-reviewed publications before the company's technology was sold to Bioness Medical. His work spans commercialization, clinical evidence generation, reimbursement, value-based care, and strategic partnerships.
CEO at Neurofenix London
Intro paths
→
In turn, Guillem can intro founders to Neurofenix London's investors below.
Neurofenix London's investors · 4
Co-founders at Neurofenix London
DA
Dimitris AthanasiouCTO
Experience
- Bioness Medical, Inc.Healthcare Innovation Consultantcurrent2025 — presentNueva York, Estados Unidos
- NeurofenixCo-founder and Chief Executive Officer2016 — 2025Nueva York, Estados Unidos
- MedTech InnovatorAccelerator Company2021Nueva York, Estados Unidos
- Entrepreneur FirstEF6 Cohort member - Technology entrepreneur2016London, Reino Unido
- Imperial College LondonBrain and Behaviour Lab - Postgraduate researcher2014 — 2015London, Reino Unido
- Institute for Bioengineering of Catalonia (IBEC)Integrated Cell and Tissue Dynamics - Graduate researcher2014Barcelona y alrededores, España
- Institute for Bioengineering of Catalonia (IBEC)Integrated Cell and Tissue Dynamics - Undergraduate researcher2013 — 2014Barcelona y alrededores, España
- Institute for Bioengineering of Catalonia (IBEC)Signal and Information Processing for Sensing Systems - Undergraduate researcher2013Barcelona y alrededores, España
- Institute for Bioengineering of Catalonia (IBEC)Integrated Cell and Tissue Dynamics - Summer Research Intern2013Barcelona y alrededores
- Institute for Bioengineering of Catalonia (IBEC)Signal and Information Processing for Sensing Systems - Undergraduate Researcher2012 — 2013Barcelona y alrededores, España
- University of BarcelonaRegulation of Lipid Metabolism - Undergraduate Researcher2012Barcelona y alrededores, España
Skills & more
Team Management2TeamworkEnglish7Cross-functional Team LeadershipGo-to-Market StrategyValue PropositionsStrategic PartnershipsBusiness StrategyHealthcare ConsultingDigital HealthInnovation ManagementMergers & Acquisitions (M&A)
+12 more
EntrepreneurshipStroke RehabilitationNeuroscienceBiomedical EngineeringMachine LearningResearchStudent RepresentationPresentation SkillsComputer VisionVirtual RealityNeurorehabilitationMatlabLanguages Catalan · English · German · Spanish
- Certificate of Proficiency in English (CPE) — Cambridge English
From Guillem's professional profile.
Frequently asked questions
- Who is Guillem Buxarrais?
- Guillem Singla Buxarrais is a healthcare strategy and innovation professional with 12 years of experience across healthcare delivery, technology, and business strategy, currently serving as a Healthcare Innovation Consultant at Bioness Medical, Inc. As Co-Founder and CEO of Neurofenix, he developed an AI-based virtual neuro-rehabilitation company that supported more than 3,000 patients, partnered with over 40 health systems and academic medical centers, secured Medicare reimbursement, raised $12M in funding, and contributed to five peer-reviewed publications before the company's technology was sold to Bioness Medical. His work spans commercialization, clinical evidence generation, reimbursement, value-based care, and strategic partnerships.
- Where does Guillem Buxarrais work?
- Guillem Buxarrais is CEO of Neurofenix London.
- What companies did Guillem Buxarrais found?
- Guillem Buxarrais founded Neurofenix London.
- Where did Guillem Buxarrais go to school?
- Guillem Buxarrais studied at Imperial College London (Master's Degree, Neurotechnology); Universitat de Barcelona (Bachelor's Degree, Biomedical Engineering).
Same school
Also attended Imperial College London643
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at MedicxiBen PerryInvestor at Medicxi
+ 637 more
Also attended Universitat de Barcelona124
Santiago ReganDirector of Business Development at Redpoint VenturesAndrea AmadorCompliance Manager at Inveready Technology Investment GroupNelson CardonaController at Inveready Technology Investment GroupJosep Maria EcharriManaging Partner & CEO at Inveready Technology Investment GroupMar FernándezMarketing & Communications Manager at Inveready Technology Investment GroupAntonio HerceDirector at Inveready Technology Investment Group
+ 118 more
Shared employers
Also worked at Bioness Medical, Inc.1
Also worked at MedTech Innovator8
David NarrowVenture Advisor at Cultivation CapitalAliya LakhanInvestor at SUPPLY CHANGE CAPITALCofield MundiPartner at Harmonix FundNick TippmannPartner at Ganas VenturesWalker McHughFounder at PreDxion BioTim KeaneFounder at TYBR Health
+ 2 more
Also worked at Entrepreneur First688
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockAravind SrinivasCo-founder & CEO of Perplexity AIToby CoppelCo-founder and Partner at Mosaic VenturesBenedict EvansWrites a weekly technology newsletter read by close to 200,000 peoplePeterDeep Tech Investment Lead at Hummingbird VenturesAniTalent Team at Hummingbird Ventures
+ 682 more
Also worked at Imperial College London160
Madison LenormandInvestor at DaphniAlptugInvestment Team at Hummingbird VenturesItxaso del PalacioGeneral Partner at Notion CapitalStephen ChambersGeneral Partner at SOSVMichelle KwokPrincipal at Draper AssociatesMercedes TuinPartner at Heran Partners
+ 154 more